CD4+ Th1 to the rescue in HER-2+ breast cancer

by Lea Lowenfeld, Shuwen Xu, Brian J. Czerniecki
Published 2019-10-01

Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy

by Julia Terhune, Erik Berk, Brian J. Czerniecki
Published 2013-11-01

Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy

by Amrita Basu, Ganesan Ramamoorthi, Gabriella Albert, Corey Gallen, Amber Beyer, Colin Snyder, Gary Koski, Mary L. Disis, Brian J. Czerniecki, Brian J. Czerniecki, Brian J. Czerniecki, Krithika Kodumudi, Krithika Kodumudi
Published 2021-05-01

Murine Dendritic Cells Grown in Serum-Free Culture Show Potent Therapeutic Activity when Loaded with Novel Th Epitopes in an Orthotopic Model of HER2^pos Breast Cancer

by Loral E. Showalter, Brian J. Czerniecki, Krithika Kodumudi, Gary K. Koski
Published 2021-09-01

Occult Breast Carcinoma Presenting as Scalp Metastasis

by Ricardo L.B. Costa, Rubens B. Costa-Filho, Marilin Rosa, Brian J. Czerniecki
Published 2017-11-01

Sunitinib Combined with Th1 Cytokines Potentiates Apoptosis in Human Breast Cancer Cells and Suppresses Tumor Growth in a Murine Model of HER-2pos Breast Cancer

by Nirmala Ghimirey, Chase Steele, Brian J. Czerniecki, Gary K. Koski, Loral E. Showalter
Published 2021-01-01

Th1 cytokines sensitize HER-expressing breast cancer cells to lapatinib.

by Loral E Showalter, Crystal Oechsle, Nirmala Ghimirey, Chase Steele, Brian J Czerniecki, Gary K Koski
Published 2019-01-01

Inhibition of CD4+CD25+ regulatory T cell function and conversion into Th1-like effectors by a Toll-like receptor-activated dendritic cell vaccine.

by Major K Lee, Shuwen Xu, Elizabeth H Fitzpatrick, Anupama Sharma, Holly L Graves, Brian J Czerniecki
Published 2013-01-01

Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention

by Nadia F Nocera, M. Catherine Lee, Lucy M. De La Cruz, Cinthia Rosemblit, Brian J. Czerniecki
Published 2016-10-01

Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy

by Yael Artzy-Randrup, Tamir Epstein, Joel S. Brown, Ricardo L. B. Costa, Brian J. Czerniecki, Robert A. Gatenby
Published 2021-03-01

Rationale for a multimodality strategy to enhance the efficacy of dendritic cell-based cancer immunotherapy

by Jashodeep eDatta, Erik eBerk, Jessica A Cintolo, Shuwen eXu, Robert E Roses, Brian J Czerniecki
Published 2015-06-01

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the...

by Krithika N. Kodumudi, Ganesan Ramamoorthi, Colin Snyder, Amrita Basu, Yongsheng Jia, Yongsheng Jia, Sabrina Awshah, Amber P. Beyer, Doris Wiener, Lian Lam, Hongtao Zhang, Mark I. Greene, Ricardo L. B. Costa, Ricardo L. B. Costa, Brian J. Czerniecki, Brian J. Czerniecki
Published 2019-08-01

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

by Jan Poleszczuk, Kimberly Luddy, Lu Chen, Jae K. Lee, Louis B. Harrison, Brian J. Czerniecki, Hatem Soliman, Heiko Enderling
Published 2017-06-01

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination

by Nadia Nocera Zachariah, Amrita Basu, Namrata Gautam, Ganesan Ramamoorthi, Krithika N. Kodumudi, Nagi B. Kumar, Loretta Loftus, Brian J. Czerniecki
Published 2021-11-01

Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17.

by Christopher Paustian, Patricia Taylor, Terrence Johnson, Min Xu, Nancy Ramirez, Kenneth S Rosenthal, Suyu Shu, Peter A Cohen, Brian J Czerniecki, Gary K Koski
Published 2013-01-01

Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.

by Cheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, Rosemarie Mick, Thomas Garrabrant, Brian J Czerniecki, Lana E Kandalaft, Daniel J Powell, George Coukos
Published 2011-01-01

HER3 Expression Is a Marker of Tumor Progression in Premalignant Lesions of the Gastroesophageal Junction.

by Brett L Ecker, Laura Taylor, Paul J Zhang, Emma E Furth, Gregory G Ginsberg, Matthew T McMillan, Jashodeep Datta, Brian J Czerniecki, Robert E Roses
Published 2016-01-01

Long-Term CD4⁺ T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study

by Corey Gallen, Christopher W. Dukes, Amy Aldrich, Lauren Macaisa, Qianxing Mo, Christopher L. Cubitt, Shari Pilon-Thomas, Anna R. Giuliano, Brian J. Czerniecki, Ricardo L. B. Costa
Published 2022-11-01

Personalizing Radiation Treatment Delivery in the Management of Breast Cancer

by Kamran A. Ahmed, G. Daniel Grass, Amber G. Orman, Casey Liveringhouse, Michael E. Montejo, Hatem H. Soliman, Heather S. Han, Brian J. Czerniecki, Javier F. Torres-Roca, Roberto Diaz
Published 2018-01-01

Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma

by Krithika Kodumudi, Brian J Czerniecki, Doris Wiener, Ganesan Ramamoorthi, Colin Snyder, Payal Grover, Hongtao Zhang, Mark I Greene, Amrita Basu, Corey Gallen, Ricardo L B Costa, Hyo S Han, Gary Koski
Published 2022-06-01